Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : CYTC - How High Can It Go! -- Ignore unavailable to you. Want to Upgrade?

To: Ted Downs who wrote (56)	11/20/1997 8:36:00 PM
From: Cisco	Read Replies (2) \| Respond to of 185

Ted, Trust me, I am probably as much confused as you are. I would gladly accept any insight you might have. What I have been dicussing on ACMI thread is that there appears to be more and more uneasiness within the professional community about the claims of these system. The report I cited talked a lot about the questions concerning CYTC that was coming up in hallway talk at the early November conference. If you look at CYTC stock price it took a signficant drop immediately afterward from 25 3/8 to 20 3/4. I believe that ACMI will eventually benefit because it is the only system that actually reduces overall cost. It can be used with any of the various smear techniques. And lacks many of the questions being raised about the primary screening systems. I would expect the professional community to recognize this first, which should translate into increase sales which should make ACMI profitable. At some point I would expect the street to recognize it. I am disappointed that ACMI stock is down, but I am not surprised. I still believe I have a much better chance of seeing ACMI at 4.00 than to see CYTC at 48.00 withing the next few months. I never planned to be in ACMI long term. But sometimes market trends catch you by surprise. I believe that anyone who invests in this industry should be aware they are investing in high risk investments. I do not view CYTC as a direct competor of ACMI except that ACMI would need FDA approval to read CYTC's ThinPrep. ACMI major threat short term is NPTH. You state the article is obviously well known. That I doubt. Take a look at Frank's Post: techstocks.com For a balance view, also read John's post: techstocks.com He obviously disagrees with my assessment. I guess time will tell. But I certianly wish you the best in whichever direction you decide to go. Cisco